World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 May 2023
Main ID:  PACTR201507001178614
Date of registration: 22/06/2015
Prospective Registration: Yes
Primary sponsor: Clinton Health Access Initiative
Public title: Integration of EPI and Pediatric HIV Services for Improved ART Initiation
Scientific title: Integration of EPI and Pediatric HIV Services for Improved ART Initiation
Date of first enrolment: 27/07/2015
Target sample size: 15160
Recruitment status: Pending
URL:  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=1178
Study type:  Interventional
Study design:  Parallel: different groups receive different interventions at same time during study,Randomised,Allocation will be done using a program in Stata with a random seed to improve reproducibility. Randomization will be stratified according to the first primary outcome, and will use the minimum maximum t-statistic method to ensure maximum balance on covariates,All allocations to intervention and control will be done simultaneously in Stata  
Phase:  Not Applicable
Countries of recruitment
Zimbabwe
Contacts
Name: Brett    Keller
Address:  Skyways Building, 3rd Floor. Ohio and Sokoine Drive Dar es Salaam Tanzania
Telephone: +18579390304
Email: bkeller@clintonhealthaccess.org
Affiliation:  Technical Advisor, Clinton Health Access Initaitive
Name: Brett    Keller
Address:  Skyways Building, 3rd Floor. Ohio and Sokoine Drive Dar es Salaam Tanzania
Telephone: +18579390304
Email: bkeller@clintonhealthaccess.org
Affiliation:  Technical Advisor, Clinton Health Access Initaitive
Key inclusion & exclusion criteria
Inclusion criteria: All public health facilities across Zimbabwe that provide ART and EPI services will be eligible for the study, provided they do not have active relevant research ongoing at the site; site has provided Penta1 services to at least 500 infants in the previous eight months; and site is reasonably accessible for study
staff to visit.

Exclusion criteria: Sites within ten kilometers of another eligible facility will be excluded, as will facilities with active research related to EPI services, ART initiation, or other subjects that could directly impact
this study.


Age minimum: 0 Year(s)
Age maximum: 2 Year(s)
Gender: Both
Health Condition(s) or Problem(s) studied

HIV/AIDS
HIV/AIDS
Intervention(s)
Control (standard of care) group
Intervention group
Primary Outcome(s)
The proportion of infants coming for Penta1 visit who initiate ART by age 16 weeks
The average age of infants initiating on ART for all infants who initiate ART by age 2 years
Secondary Outcome(s)
the total number of infants less than two years of age tested for HIV
the proportion of infants less than two years testing HIV positive who initiate on ART
the proportion of infants coming for a Penta1 visit who are tested for HIV by age 12 weeks
the turnaround time between testing and receiving HIV results for infants less than two years
the total number of infants less than two years of age initiating on ART during the study period;
the total number of infants receiving Penta1 immunizations
the cost per additional ART initiation by age 16 weeks
the proportion of HIV testing results from Penta1 visits available at Penta2 visits
the cost per additional HIV test for children under 12 weeks
Secondary ID(s)
Source(s) of Monetary Support
International Initiative for Impact Evaluation
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 29/05/2015
Contact:
Chesapeake Institutional Review Board
Status: Not approved
Approval date:
Contact:
Medical Research Council of Zimbabwe
Status: Not approved
Approval date:
Contact:
Research Council of Zimbabwe
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history